Clinical Trial Details

EORTC-55961

Back to Clinical Trials Database

EORTC 55961,Phase II study on Paclitaxel in recurrent uterine papillary serous carcinoma (UPSC)

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 07-Jun-2001
Date Step1 close: 30-Oct-2002
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 29
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00022620
NCT number NCT00022620